nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—ABCB1—peripheral nervous system neoplasm	0.161	1	CbGaD
Diclofenac—CYP2C18—Tretinoin—peripheral nervous system neoplasm	0.0697	0.127	CbGbCtD
Diclofenac—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0356	0.0648	CbGbCtD
Diclofenac—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0349	0.0636	CbGbCtD
Diclofenac—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0289	0.0527	CbGbCtD
Diclofenac—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0253	0.0461	CbGbCtD
Diclofenac—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0249	0.0453	CbGbCtD
Diclofenac—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.024	0.0437	CbGbCtD
Diclofenac—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0221	0.0401	CbGbCtD
Diclofenac—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0215	0.0392	CbGbCtD
Diclofenac—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0197	0.0359	CbGbCtD
Diclofenac—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0192	0.035	CbGbCtD
Diclofenac—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0167	0.0304	CbGbCtD
Diclofenac—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0147	0.0267	CbGbCtD
Diclofenac—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0144	0.0262	CbGbCtD
Diclofenac—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0139	0.0253	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0134	0.0245	CbGbCtD
Diclofenac—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0122	0.0222	CbGbCtD
Diclofenac—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0122	0.0221	CbGbCtD
Diclofenac—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0122	0.0221	CbGbCtD
Diclofenac—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0117	0.0212	CbGbCtD
Diclofenac—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0111	0.0202	CbGbCtD
Diclofenac—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.00945	0.0172	CbGbCtD
Diclofenac—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.00941	0.0171	CbGbCtD
Diclofenac—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00843	0.0153	CbGbCtD
Diclofenac—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00729	0.0133	CbGbCtD
Diclofenac—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00703	0.0128	CbGbCtD
Diclofenac—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00678	0.0123	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.00633	0.0115	CbGbCtD
Diclofenac—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00544	0.0099	CbGbCtD
Diclofenac—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00519	0.00945	CbGbCtD
Diclofenac—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00499	0.00908	CbGbCtD
Diclofenac—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00484	0.00881	CbGbCtD
Diclofenac—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00476	0.00866	CbGbCtD
Diclofenac—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00325	0.00591	CbGbCtD
Diclofenac—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00311	0.00566	CbGbCtD
Diclofenac—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00285	0.00519	CbGbCtD
Diclofenac—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00194	0.00354	CbGbCtD
Diclofenac—ASIC1—ganglion—peripheral nervous system neoplasm	0.00116	0.18	CbGeAlD
Diclofenac—PLA2G2A—tongue—peripheral nervous system neoplasm	0.000691	0.107	CbGeAlD
Diclofenac—SLCO1C1—ganglion—peripheral nervous system neoplasm	0.00059	0.0917	CbGeAlD
Diclofenac—ASIC1—trigeminal ganglion—peripheral nervous system neoplasm	0.000569	0.0885	CbGeAlD
Diclofenac—KCNQ2—brainstem—peripheral nervous system neoplasm	0.000369	0.0573	CbGeAlD
Diclofenac—PLA2G2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000343	0.0533	CbGeAlD
Diclofenac—CXCL8—trigeminal ganglion—peripheral nervous system neoplasm	0.00034	0.0528	CbGeAlD
Diclofenac—TTR—trigeminal ganglion—peripheral nervous system neoplasm	0.000259	0.0403	CbGeAlD
Diclofenac—ASIC1—cerebellum—peripheral nervous system neoplasm	0.000248	0.0386	CbGeAlD
Diclofenac—TTR—brainstem—peripheral nervous system neoplasm	0.000229	0.0356	CbGeAlD
Diclofenac—KCNQ3—cerebellum—peripheral nervous system neoplasm	0.000197	0.0307	CbGeAlD
Diclofenac—PTGS1—ganglion—peripheral nervous system neoplasm	0.000192	0.0298	CbGeAlD
Diclofenac—KCNQ2—cerebellum—peripheral nervous system neoplasm	0.000182	0.0283	CbGeAlD
Diclofenac—SLC22A8—trigeminal ganglion—peripheral nervous system neoplasm	0.000159	0.0247	CbGeAlD
Diclofenac—CXCL8—cerebellum—peripheral nervous system neoplasm	0.000148	0.023	CbGeAlD
Diclofenac—ABCC1—parotid gland—peripheral nervous system neoplasm	0.000129	0.02	CbGeAlD
Diclofenac—TTR—cerebellum—peripheral nervous system neoplasm	0.000113	0.0176	CbGeAlD
Diclofenac—ALOX5—cerebellum—peripheral nervous system neoplasm	0.000102	0.0159	CbGeAlD
Diclofenac—CYP1A1—parotid gland—peripheral nervous system neoplasm	0.000101	0.0157	CbGeAlD
Diclofenac—PTGS2—trigeminal ganglion—peripheral nervous system neoplasm	9e-05	0.014	CbGeAlD
Diclofenac—ABCC1—cerebellum—peripheral nervous system neoplasm	5.95e-05	0.00926	CbGeAlD
Diclofenac—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	5.57e-05	0.00866	CbGeAlD
Diclofenac—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000207	CcSEcCtD
Diclofenac—Jaundice—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000207	CcSEcCtD
Diclofenac—Constipation—Etoposide—peripheral nervous system neoplasm	4.7e-05	0.000206	CcSEcCtD
Diclofenac—Pain—Etoposide—peripheral nervous system neoplasm	4.7e-05	0.000206	CcSEcCtD
Diclofenac—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	4.69e-05	0.000206	CcSEcCtD
Diclofenac—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	4.69e-05	0.000206	CcSEcCtD
Diclofenac—Dysuria—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000206	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000204	CcSEcCtD
Diclofenac—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.66e-05	0.000204	CcSEcCtD
Diclofenac—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.64e-05	0.000204	CcSEcCtD
Diclofenac—Sweating—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.000203	CcSEcCtD
Diclofenac—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000203	CcSEcCtD
Diclofenac—Haematuria—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000202	CcSEcCtD
Diclofenac—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.000201	CcSEcCtD
Diclofenac—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.57e-05	0.0002	CcSEcCtD
Diclofenac—Weight increased—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.0002	CcSEcCtD
Diclofenac—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.0002	CcSEcCtD
Diclofenac—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.000199	CcSEcCtD
Diclofenac—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000199	CcSEcCtD
Diclofenac—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.53e-05	0.000199	CcSEcCtD
Diclofenac—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000198	CcSEcCtD
Diclofenac—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.51e-05	0.000198	CcSEcCtD
Diclofenac—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000198	CcSEcCtD
Diclofenac—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.000197	CcSEcCtD
Diclofenac—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.49e-05	0.000197	CcSEcCtD
Diclofenac—Dizziness—Vincristine—peripheral nervous system neoplasm	4.49e-05	0.000197	CcSEcCtD
Diclofenac—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.48e-05	0.000196	CcSEcCtD
Diclofenac—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000196	CcSEcCtD
Diclofenac—Infestation—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000196	CcSEcCtD
Diclofenac—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000196	CcSEcCtD
Diclofenac—Rash—Alitretinoin—peripheral nervous system neoplasm	4.44e-05	0.000195	CcSEcCtD
Diclofenac—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.43e-05	0.000195	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000194	CcSEcCtD
Diclofenac—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.42e-05	0.000194	CcSEcCtD
Diclofenac—Bradycardia—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000194	CcSEcCtD
Diclofenac—Headache—Alitretinoin—peripheral nervous system neoplasm	4.41e-05	0.000193	CcSEcCtD
Diclofenac—Renal failure—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000193	CcSEcCtD
Diclofenac—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000192	CcSEcCtD
Diclofenac—Urticaria—Etoposide—peripheral nervous system neoplasm	4.37e-05	0.000192	CcSEcCtD
Diclofenac—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000191	CcSEcCtD
Diclofenac—Jaundice—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000191	CcSEcCtD
Diclofenac—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000191	CcSEcCtD
Diclofenac—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000191	CcSEcCtD
Diclofenac—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.34e-05	0.000191	CcSEcCtD
Diclofenac—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.34e-05	0.000191	CcSEcCtD
Diclofenac—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.34e-05	0.000191	CcSEcCtD
Diclofenac—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.34e-05	0.000191	CcSEcCtD
Diclofenac—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.00019	CcSEcCtD
Diclofenac—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.00019	CcSEcCtD
Diclofenac—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000189	CcSEcCtD
Diclofenac—Vomiting—Vincristine—peripheral nervous system neoplasm	4.31e-05	0.000189	CcSEcCtD
Diclofenac—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.3e-05	0.000189	CcSEcCtD
Diclofenac—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000189	CcSEcCtD
Diclofenac—Sweating—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.000188	CcSEcCtD
Diclofenac—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000188	CcSEcCtD
Diclofenac—Rash—Vincristine—peripheral nervous system neoplasm	4.28e-05	0.000188	CcSEcCtD
Diclofenac—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.27e-05	0.000187	CcSEcCtD
Diclofenac—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	4.27e-05	0.000187	CcSEcCtD
Diclofenac—CYP2E1—cerebellum—peripheral nervous system neoplasm	4.27e-05	0.00663	CbGeAlD
Diclofenac—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.000187	CcSEcCtD
Diclofenac—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.25e-05	0.000186	CcSEcCtD
Diclofenac—Headache—Vincristine—peripheral nervous system neoplasm	4.25e-05	0.000186	CcSEcCtD
Diclofenac—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.23e-05	0.000185	CcSEcCtD
Diclofenac—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000185	CcSEcCtD
Diclofenac—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000184	CcSEcCtD
Diclofenac—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.18e-05	0.000183	CcSEcCtD
Diclofenac—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.000183	CcSEcCtD
Diclofenac—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000183	CcSEcCtD
Diclofenac—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.1e-05	0.00018	CcSEcCtD
Diclofenac—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	4.1e-05	0.00018	CcSEcCtD
Diclofenac—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.000179	CcSEcCtD
Diclofenac—Eye disorder—Epirubicin—peripheral nervous system neoplasm	4.05e-05	0.000178	CcSEcCtD
Diclofenac—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.05e-05	0.000178	CcSEcCtD
Diclofenac—Tinnitus—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000177	CcSEcCtD
Diclofenac—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000177	CcSEcCtD
Diclofenac—Nausea—Vincristine—peripheral nervous system neoplasm	4.03e-05	0.000177	CcSEcCtD
Diclofenac—Flushing—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000177	CcSEcCtD
Diclofenac—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000177	CcSEcCtD
Diclofenac—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000176	CcSEcCtD
Diclofenac—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000176	CcSEcCtD
Diclofenac—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000176	CcSEcCtD
Diclofenac—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000175	CcSEcCtD
Diclofenac—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000175	CcSEcCtD
Diclofenac—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000174	CcSEcCtD
Diclofenac—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	3.95e-05	0.000173	CcSEcCtD
Diclofenac—Asthenia—Etoposide—peripheral nervous system neoplasm	3.94e-05	0.000173	CcSEcCtD
Diclofenac—Angiopathy—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.000173	CcSEcCtD
Diclofenac—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	3.93e-05	0.000173	CcSEcCtD
Diclofenac—PTGS2—cerebellum—peripheral nervous system neoplasm	3.93e-05	0.00611	CbGeAlD
Diclofenac—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000172	CcSEcCtD
Diclofenac—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	3.91e-05	0.000171	CcSEcCtD
Diclofenac—Chills—Epirubicin—peripheral nervous system neoplasm	3.89e-05	0.000171	CcSEcCtD
Diclofenac—Pruritus—Etoposide—peripheral nervous system neoplasm	3.89e-05	0.000171	CcSEcCtD
Diclofenac—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.00017	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.00017	CcSEcCtD
Diclofenac—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.000168	CcSEcCtD
Diclofenac—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.81e-05	0.000167	CcSEcCtD
Diclofenac—Mental disorder—Epirubicin—peripheral nervous system neoplasm	3.8e-05	0.000167	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	3.79e-05	0.000166	CcSEcCtD
Diclofenac—Rash—Cisplatin—peripheral nervous system neoplasm	3.78e-05	0.000166	CcSEcCtD
Diclofenac—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.78e-05	0.000166	CcSEcCtD
Diclofenac—Erythema—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000166	CcSEcCtD
Diclofenac—Malnutrition—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000166	CcSEcCtD
Diclofenac—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.76e-05	0.000165	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000164	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	3.74e-05	0.000164	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.000163	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.000163	CcSEcCtD
Diclofenac—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.000163	CcSEcCtD
Diclofenac—Tension—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000162	CcSEcCtD
Diclofenac—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000162	CcSEcCtD
Diclofenac—Nervousness—Epirubicin—peripheral nervous system neoplasm	3.67e-05	0.000161	CcSEcCtD
Diclofenac—Back pain—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.00016	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.64e-05	0.00016	CcSEcCtD
Diclofenac—Dizziness—Etoposide—peripheral nervous system neoplasm	3.63e-05	0.000159	CcSEcCtD
Diclofenac—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.63e-05	0.000159	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	3.62e-05	0.000159	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.62e-05	0.000159	CcSEcCtD
Diclofenac—Chills—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.000158	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000157	CcSEcCtD
Diclofenac—Nausea—Cisplatin—peripheral nervous system neoplasm	3.56e-05	0.000156	CcSEcCtD
Diclofenac—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000156	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000156	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.51e-05	0.000154	CcSEcCtD
Diclofenac—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.000154	CcSEcCtD
Diclofenac—Vomiting—Etoposide—peripheral nervous system neoplasm	3.49e-05	0.000153	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000153	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000153	CcSEcCtD
Diclofenac—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000153	CcSEcCtD
Diclofenac—Agitation—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000152	CcSEcCtD
Diclofenac—Rash—Etoposide—peripheral nervous system neoplasm	3.46e-05	0.000152	CcSEcCtD
Diclofenac—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.46e-05	0.000152	CcSEcCtD
Diclofenac—Headache—Etoposide—peripheral nervous system neoplasm	3.44e-05	0.000151	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.000151	CcSEcCtD
Diclofenac—Tension—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.00015	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.00015	CcSEcCtD
Diclofenac—Malaise—Epirubicin—peripheral nervous system neoplasm	3.4e-05	0.000149	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.39e-05	0.000149	CcSEcCtD
Diclofenac—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000149	CcSEcCtD
Diclofenac—Syncope—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000149	CcSEcCtD
Diclofenac—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000148	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000148	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.36e-05	0.000147	CcSEcCtD
Diclofenac—Palpitations—Epirubicin—peripheral nervous system neoplasm	3.34e-05	0.000146	CcSEcCtD
Diclofenac—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.32e-05	0.000146	CcSEcCtD
Diclofenac—Cough—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000145	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000144	CcSEcCtD
Diclofenac—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000143	CcSEcCtD
Diclofenac—Nausea—Etoposide—peripheral nervous system neoplasm	3.26e-05	0.000143	CcSEcCtD
Diclofenac—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.26e-05	0.000143	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000142	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000142	CcSEcCtD
Diclofenac—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000141	CcSEcCtD
Diclofenac—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000141	CcSEcCtD
Diclofenac—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000141	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000141	CcSEcCtD
Diclofenac—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.00014	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.19e-05	0.00014	CcSEcCtD
Diclofenac—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000139	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000138	CcSEcCtD
Diclofenac—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000138	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.14e-05	0.000138	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000137	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000137	CcSEcCtD
Diclofenac—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.000136	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.000135	CcSEcCtD
Diclofenac—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000135	CcSEcCtD
Diclofenac—Oedema—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000135	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000135	CcSEcCtD
Diclofenac—Infection—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000134	CcSEcCtD
Diclofenac—Cough—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000134	CcSEcCtD
Diclofenac—Shock—Epirubicin—peripheral nervous system neoplasm	3.03e-05	0.000133	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000133	CcSEcCtD
Diclofenac—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.02e-05	0.000133	CcSEcCtD
Diclofenac—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.02e-05	0.000132	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000132	CcSEcCtD
Diclofenac—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.01e-05	0.000132	CcSEcCtD
Diclofenac—Skin disorder—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000131	CcSEcCtD
Diclofenac—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000131	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.00013	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.00013	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.00013	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.00013	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.00013	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.94e-05	0.000129	CcSEcCtD
Diclofenac—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.000129	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.000128	CcSEcCtD
Diclofenac—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.88e-05	0.000126	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—peripheral nervous system neoplasm	2.87e-05	0.000126	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000125	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000125	CcSEcCtD
Diclofenac—Infection—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000124	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.81e-05	0.000123	CcSEcCtD
Diclofenac—Shock—Doxorubicin—peripheral nervous system neoplasm	2.8e-05	0.000123	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.8e-05	0.000123	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.79e-05	0.000122	CcSEcCtD
Diclofenac—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.000122	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	0.000122	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000121	CcSEcCtD
Diclofenac—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.77e-05	0.000121	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000121	CcSEcCtD
Diclofenac—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.00012	CcSEcCtD
Diclofenac—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.74e-05	0.00012	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000119	CcSEcCtD
Diclofenac—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.71e-05	0.000119	CcSEcCtD
Diclofenac—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.68e-05	0.000117	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.66e-05	0.000117	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.66e-05	0.000117	CcSEcCtD
Diclofenac—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.66e-05	0.000117	CcSEcCtD
Diclofenac—Pain—Epirubicin—peripheral nervous system neoplasm	2.63e-05	0.000116	CcSEcCtD
Diclofenac—Constipation—Epirubicin—peripheral nervous system neoplasm	2.63e-05	0.000116	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.6e-05	0.000114	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.000113	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.56e-05	0.000112	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.54e-05	0.000111	CcSEcCtD
Diclofenac—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000111	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.53e-05	0.000111	CcSEcCtD
Diclofenac—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.52e-05	0.000111	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.00011	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	0.000109	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.46e-05	0.000108	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.46e-05	0.000108	CcSEcCtD
Diclofenac—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.45e-05	0.000107	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.44e-05	0.000107	CcSEcCtD
Diclofenac—Pain—Doxorubicin—peripheral nervous system neoplasm	2.44e-05	0.000107	CcSEcCtD
Diclofenac—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.44e-05	0.000107	CcSEcCtD
Diclofenac—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.44e-05	0.000107	CcSEcCtD
Diclofenac—ABCB1—cerebellum—peripheral nervous system neoplasm	2.43e-05	0.00378	CbGeAlD
Diclofenac—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	0.000103	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.33e-05	0.000102	CcSEcCtD
Diclofenac—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.27e-05	9.96e-05	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.26e-05	9.93e-05	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.25e-05	9.89e-05	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.25e-05	9.89e-05	CcSEcCtD
Diclofenac—TTR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.22e-05	0.000401	CbGpPWpGaD
Diclofenac—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.21e-05	9.7e-05	CcSEcCtD
Diclofenac—KCNQ2—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.21e-05	0.000399	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.21e-05	0.000399	CbGpPWpGaD
Diclofenac—TTR—Disease—PTPN11—peripheral nervous system neoplasm	2.2e-05	0.000398	CbGpPWpGaD
Diclofenac—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.18e-05	9.56e-05	CcSEcCtD
Diclofenac—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	2.14e-05	0.000386	CbGpPWpGaD
Diclofenac—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.11e-05	9.25e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.1e-05	9.21e-05	CcSEcCtD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.09e-05	0.000377	CbGpPWpGaD
Diclofenac—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.04e-05	8.97e-05	CcSEcCtD
Diclofenac—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.04e-05	8.94e-05	CcSEcCtD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.02e-05	0.000366	CbGpPWpGaD
Diclofenac—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.02e-05	8.85e-05	CcSEcCtD
Diclofenac—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.99e-05	0.00036	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.99e-05	0.000359	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—BCHE—peripheral nervous system neoplasm	1.99e-05	0.000359	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	1.98e-05	0.000358	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	1.97e-05	0.000356	CbGpPWpGaD
Diclofenac—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.96e-05	8.59e-05	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.95e-05	8.56e-05	CcSEcCtD
Diclofenac—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.95e-05	0.000351	CbGpPWpGaD
Diclofenac—Rash—Epirubicin—peripheral nervous system neoplasm	1.94e-05	8.52e-05	CcSEcCtD
Diclofenac—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.94e-05	8.51e-05	CcSEcCtD
Diclofenac—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	1.93e-05	0.000349	CbGpPWpGaD
Diclofenac—Headache—Epirubicin—peripheral nervous system neoplasm	1.93e-05	8.47e-05	CcSEcCtD
Diclofenac—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.92e-05	0.000347	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	1.91e-05	0.000344	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	1.9e-05	0.000344	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.9e-05	0.000342	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.89e-05	0.000342	CbGpPWpGaD
Diclofenac—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.88e-05	8.27e-05	CcSEcCtD
Diclofenac—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.88e-05	0.000339	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	1.87e-05	0.000337	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—TH—peripheral nervous system neoplasm	1.87e-05	0.000337	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.86e-05	0.000336	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.86e-05	0.000335	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.84e-05	0.000333	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.84e-05	0.000333	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	1.83e-05	0.000331	CbGpPWpGaD
Diclofenac—Nausea—Epirubicin—peripheral nervous system neoplasm	1.83e-05	8.03e-05	CcSEcCtD
Diclofenac—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	1.83e-05	0.00033	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.82e-05	0.000328	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	1.82e-05	0.000328	CbGpPWpGaD
Diclofenac—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.81e-05	7.95e-05	CcSEcCtD
Diclofenac—CXCR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.81e-05	0.000327	CbGpPWpGaD
Diclofenac—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.8e-05	0.000325	CbGpPWpGaD
Diclofenac—Rash—Doxorubicin—peripheral nervous system neoplasm	1.8e-05	7.88e-05	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.8e-05	7.88e-05	CcSEcCtD
Diclofenac—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.79e-05	0.000324	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	1.79e-05	0.000323	CbGpPWpGaD
Diclofenac—Headache—Doxorubicin—peripheral nervous system neoplasm	1.79e-05	7.83e-05	CcSEcCtD
Diclofenac—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.78e-05	0.000321	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.77e-05	0.00032	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	1.76e-05	0.000318	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	1.76e-05	0.000318	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.75e-05	0.000316	CbGpPWpGaD
Diclofenac—TTR—Disease—ERBB2—peripheral nervous system neoplasm	1.74e-05	0.000314	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.72e-05	0.000311	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	1.72e-05	0.000311	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.71e-05	0.000308	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.7e-05	0.000307	CbGpPWpGaD
Diclofenac—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.69e-05	7.43e-05	CcSEcCtD
Diclofenac—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	1.69e-05	0.000305	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000302	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.67e-05	0.000302	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.66e-05	0.0003	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	1.66e-05	0.000299	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.66e-05	0.000299	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.64e-05	0.000297	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.63e-05	0.000295	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.63e-05	0.000295	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	1.62e-05	0.000294	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.62e-05	0.000293	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.61e-05	0.000292	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.61e-05	0.00029	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.57e-05	0.000283	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.56e-05	0.000281	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.55e-05	0.000281	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.55e-05	0.00028	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.54e-05	0.000278	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.54e-05	0.000278	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GNAS—peripheral nervous system neoplasm	1.52e-05	0.000275	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	1.51e-05	0.000274	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.51e-05	0.000273	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.51e-05	0.000273	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.51e-05	0.000272	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.5e-05	0.00027	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—ABCB1—peripheral nervous system neoplasm	1.5e-05	0.00027	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.49e-05	0.000269	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.49e-05	0.000269	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	1.48e-05	0.000268	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.48e-05	0.000268	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.48e-05	0.000268	CbGpPWpGaD
Diclofenac—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.48e-05	0.000268	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—TH—peripheral nervous system neoplasm	1.48e-05	0.000267	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.47e-05	0.000265	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.45e-05	0.000263	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.44e-05	0.000261	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.44e-05	0.00026	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	1.44e-05	0.000259	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	1.44e-05	0.000259	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.42e-05	0.000257	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.41e-05	0.000254	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.38e-05	0.00025	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.38e-05	0.000249	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.35e-05	0.000244	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000243	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.34e-05	0.000242	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.33e-05	0.00024	CbGpPWpGaD
Diclofenac—TTR—Disease—NRAS—peripheral nervous system neoplasm	1.32e-05	0.000239	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.32e-05	0.000239	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.31e-05	0.000237	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.3e-05	0.000234	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.29e-05	0.000233	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.28e-05	0.000232	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	1.28e-05	0.000231	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.26e-05	0.000228	CbGpPWpGaD
Diclofenac—TTR—Disease—MYC—peripheral nervous system neoplasm	1.23e-05	0.000223	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.22e-05	0.00022	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.22e-05	0.00022	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.21e-05	0.000219	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.2e-05	0.000218	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	1.2e-05	0.000217	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	1.2e-05	0.000217	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.2e-05	0.000216	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.18e-05	0.000214	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.18e-05	0.000213	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	1.16e-05	0.00021	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	1.16e-05	0.000209	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.16e-05	0.000209	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	1.16e-05	0.000209	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.14e-05	0.000206	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	1.13e-05	0.000204	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.13e-05	0.000204	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.12e-05	0.000203	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.11e-05	0.0002	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	1.1e-05	0.000198	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.08e-05	0.000195	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.08e-05	0.000194	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.07e-05	0.000193	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.05e-05	0.00019	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.05e-05	0.00019	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	1.05e-05	0.00019	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.04e-05	0.000187	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.03e-05	0.000187	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	1.02e-05	0.000183	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.01e-05	0.000182	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	9.82e-06	0.000177	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	9.78e-06	0.000177	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	9.76e-06	0.000176	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	9.72e-06	0.000176	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.69e-06	0.000175	CbGpPWpGaD
Diclofenac—TTR—Disease—HRAS—peripheral nervous system neoplasm	9.68e-06	0.000175	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	9.64e-06	0.000174	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.64e-06	0.000174	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	9.56e-06	0.000173	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	9.55e-06	0.000172	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	9.5e-06	0.000172	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.31e-06	0.000168	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	9.28e-06	0.000168	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.27e-06	0.000167	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	9.18e-06	0.000166	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.12e-06	0.000165	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	9.01e-06	0.000163	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	8.99e-06	0.000162	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.9e-06	0.000161	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	8.73e-06	0.000158	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	8.66e-06	0.000157	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.63e-06	0.000156	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.6e-06	0.000155	CbGpPWpGaD
Diclofenac—TTR—Disease—AKT1—peripheral nervous system neoplasm	8.55e-06	0.000154	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	8.52e-06	0.000154	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	8.47e-06	0.000153	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—AKT1—peripheral nervous system neoplasm	8.33e-06	0.00015	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	8.31e-06	0.00015	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	8.26e-06	0.000149	CbGpPWpGaD
Diclofenac—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	8.22e-06	0.000148	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.17e-06	0.000148	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	8.14e-06	0.000147	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.02e-06	0.000145	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	8e-06	0.000144	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	7.96e-06	0.000144	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.88e-06	0.000142	CbGpPWpGaD
Diclofenac—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.84e-06	0.000142	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	7.79e-06	0.000141	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	7.77e-06	0.00014	CbGpPWpGaD
Diclofenac—ALB—Metabolism—TH—peripheral nervous system neoplasm	7.73e-06	0.00014	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.7e-06	0.000139	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.65e-06	0.000138	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	7.62e-06	0.000138	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	7.49e-06	0.000135	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.49e-06	0.000135	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.42e-06	0.000134	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	7.38e-06	0.000133	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.35e-06	0.000133	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	7.34e-06	0.000133	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.2e-06	0.00013	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	7.2e-06	0.00013	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.09e-06	0.000128	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.04e-06	0.000127	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	6.93e-06	0.000125	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	6.92e-06	0.000125	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.87e-06	0.000124	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	6.8e-06	0.000123	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.8e-06	0.000123	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.79e-06	0.000123	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.78e-06	0.000123	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	6.77e-06	0.000122	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	6.73e-06	0.000121	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	6.5e-06	0.000117	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	6.47e-06	0.000117	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.42e-06	0.000116	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	6.34e-06	0.000115	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	6.32e-06	0.000114	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	6.31e-06	0.000114	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	6.22e-06	0.000112	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.22e-06	0.000112	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	6.19e-06	0.000112	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AKT1—peripheral nervous system neoplasm	6.11e-06	0.00011	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.99e-06	0.000108	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	5.8e-06	0.000105	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.79e-06	0.000105	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	5.75e-06	0.000104	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5.66e-06	0.000102	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	5.56e-06	0.0001	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	5.53e-06	9.98e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.48e-06	9.9e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	5.4e-06	9.76e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—peripheral nervous system neoplasm	5.4e-06	9.75e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.25e-06	9.48e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	5.16e-06	9.33e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	5.11e-06	9.23e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	5.07e-06	9.15e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	4.97e-06	8.98e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.76e-06	8.59e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	4.75e-06	8.59e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.55e-06	8.22e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.44e-06	8.01e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.41e-06	7.97e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.33e-06	7.82e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	4.24e-06	7.66e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.23e-06	7.64e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	4.2e-06	7.58e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.17e-06	7.53e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—peripheral nervous system neoplasm	4.11e-06	7.43e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.02e-06	7.26e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	4e-06	7.23e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	3.89e-06	7.03e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	3.74e-06	6.76e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—peripheral nervous system neoplasm	3.62e-06	6.54e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.4e-06	6.15e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.34e-06	6.03e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	3.25e-06	5.87e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	3.14e-06	5.66e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	2.85e-06	5.14e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	2.65e-06	4.79e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	2.51e-06	4.54e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	2.1e-06	3.8e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	2.02e-06	3.65e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	1.98e-06	3.58e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.87e-06	3.37e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.71e-06	3.09e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.7e-06	3.08e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.53e-06	2.76e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.49e-06	2.69e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.39e-06	2.52e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.19e-06	2.15e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	9.19e-07	1.66e-05	CbGpPWpGaD
